Your browser doesn't support javascript.
loading
Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival
Peixoto Callejo, Isabel; Américo Brito, José; Manuel Zagalo, Carlos; Rosa Santos, Jorge.
Afiliação
  • Peixoto Callejo, Isabel; Portuguese Institute of Cancer. Lisbon. Portuga
  • Américo Brito, José; Ryerson University. Toronto. Canada
  • Manuel Zagalo, Carlos; Portuguese Institute of Cancer. Lisbon. Portuga
  • Rosa Santos, Jorge; Portuguese Institute of Cancer. Lisbon. Portuga
Clin. transl. oncol. (Print) ; 8(6): 435-443, jun. 2006. tab, graf
Artigo em En | IBECS | ID: ibc-047697
Biblioteca responsável: ES1.1
Localização: ES1.1 - BNCS
RESUMEN
No disponible
ABSTRACT
Background. Medullary thyroid carcinoma (MTC)is a rare development of thyroid cancer with a nonegligible mortality rate. Our aim was to determinefactors that predict outcome in patients with MTC.Methods. We reviewed the records of all patientswith MTC (n = 56) who underwent treatment at ourinstitution between January 1990 and December2000. Univariate and multivariate analysis of clinicopathologicpredictors of MTC outcome were performedto identify subsets of patients with differentprobabilities in terms of overall survival, local recurrence,and distant metastases.Results. Multivariate analysis demonstrated that astatistically significant decrease in overall survivalis associated with T4b tumours (p = 0.06), the presenceof distant metastases at the time of presentation(p = 0.033), lymphatic invasion (p = 0.099), andpostoperative treatment (p = 0.045).Conclusions. The analysis of survival curves of patientswith MTC shows that the occurrence of locoregionaland distant metastases occurs preferentiallywithin the first 5 years, which identifies this asa crucial period for follow-up. In this series of patientswith MTC, the tumours classified as T4b,metastases at presentation, the presence of lymphovascularinvasion, and postoperative treatment werethe most important prognostic features. At present,there is no available beneficial adjuvant therapy.However, as the development of molecular therapyprogresses, it should be tested in clinical trials withthe purpose of achievement of novel targeted therapiesfor selected MTC patients with risk factors
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Doenças do Sistema Endócrino / Neoplasia da Tireoide Base de dados: IBECS Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Medular Tipo de estudo: Estudo de etiologia / Estudo prognóstico / Fatores de risco Limite: Humanos Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2006 Tipo de documento: Artigo Instituição/País de afiliação: Portuguese Institute of Cancer/Portuga / Ryerson University/Canada
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Doenças do Sistema Endócrino / Neoplasia da Tireoide Base de dados: IBECS Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Medular Tipo de estudo: Estudo de etiologia / Estudo prognóstico / Fatores de risco Limite: Humanos Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2006 Tipo de documento: Artigo Instituição/País de afiliação: Portuguese Institute of Cancer/Portuga / Ryerson University/Canada
...